Cite
Association of residual gastric acid secretion with persistent symptoms in gastroesophageal reflux disease patients receiving standard-dose proton pump inhibitor therapy.
MLA
Kikuchi, H., et al. “Association of Residual Gastric Acid Secretion with Persistent Symptoms in Gastroesophageal Reflux Disease Patients Receiving Standard-Dose Proton Pump Inhibitor Therapy.” Esophagus : Official Journal of the Japan Esophageal Society, vol. 18, no. 2, Apr. 2021, pp. 380–87. EBSCOhost, https://doi.org/10.1007/s10388-020-00765-2.
APA
Kikuchi, H., Fukuda, S., Koike, T., Shimodaira, Y., Watanabe, K., Saito, M., Nakagawa, K., Hatta, W., Masamune, A., & Iijima, K. (2021). Association of residual gastric acid secretion with persistent symptoms in gastroesophageal reflux disease patients receiving standard-dose proton pump inhibitor therapy. Esophagus : Official Journal of the Japan Esophageal Society, 18(2), 380–387. https://doi.org/10.1007/s10388-020-00765-2
Chicago
Kikuchi, H, S Fukuda, T Koike, Y Shimodaira, K Watanabe, M Saito, K Nakagawa, W Hatta, A Masamune, and K Iijima. 2021. “Association of Residual Gastric Acid Secretion with Persistent Symptoms in Gastroesophageal Reflux Disease Patients Receiving Standard-Dose Proton Pump Inhibitor Therapy.” Esophagus : Official Journal of the Japan Esophageal Society 18 (2): 380–87. doi:10.1007/s10388-020-00765-2.